You can:
Name | Galanin receptor type 2 |
---|---|
Species | Homo sapiens (Human) |
Gene | GALR2 |
Synonym | GAL2 receptor GAL2-R GALNR2 GALR-2 |
Disease | N/A |
Length | 387 |
Amino acid sequence | MNVSGCPGAGNASQAGGGGGWHPEAVIVPLLFALIFLVGTVGNTLVLAVLLRGGQAVSTTNLFILNLGVADLCFILCCVPFQATIYTLDGWVFGSLLCKAVHFLIFLTMHASSFTLAAVSLDRYLAIRYPLHSRELRTPRNALAAIGLIWGLSLLFSGPYLSYYRQSQLANLTVCHPAWSAPRRRAMDICTFVFSYLLPVLVLGLTYARTLRYLWRAVDPVAAGSGARRAKRKVTRMILIVAALFCLCWMPHHALILCVWFGQFPLTRATYALRILSHLVSYANSCVNPIVYALVSKHFRKGFRTICAGLLGRAPGRASGRVCAAARGTHSGSVLERESSDLLHMSEAAGALRPCPGASQPCILEPCPGPSWQGPKAGDSILTVDVA |
UniProt | O43603 |
Protein Data Bank | N/A |
GPCR-HGmod model | O43603 |
3D structure model | This predicted structure model is from GPCR-EXP O43603. |
BioLiP | N/A |
Therapeutic Target Database | N/A |
ChEMBL | CHEMBL3176 |
IUPHAR | 244 |
DrugBank | N/A |
Name | CHEMBL524892 |
---|---|
Molecular formula | C97H164N22O20 |
IUPAC name | (2S)-N-[(2S)-1-[[(2S)-1-[[2-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-6-amino-1-[[(2S)-6-amino-1-[[(2S)-1-[[(2S)-1,6-diamino-1-oxohexan-2-yl]amino]-6-(hexadecanoylamino)-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-1-oxohexan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-2-oxoethyl]amino]-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]-2-[[(2S)-2-[[(2S,3R)-3-hydroxy-2-[[(2S)-3-(1H-indol-3-yl)-2-[[2-(methylamino)acetyl]amino]propanoyl]amino]butanoyl]amino]-4-methylpentanoyl]amino]butanediamide |
Molecular weight | 1958.51 |
Hydrogen bond acceptor | 24 |
Hydrogen bond donor | 25 |
XlogP | 5.2 |
Synonyms | BDBM50273365 |
Inchi Key | BEJMLCDPLQEJMU-SIZCXABRSA-N |
Inchi ID | InChI=1S/C97H164N22O20/c1-11-12-13-14-15-16-17-18-19-20-21-22-23-40-81(124)104-48-33-29-39-72(87(129)110-69(85(102)127)36-26-30-45-98)112-88(130)70(37-27-31-46-99)111-89(131)71(38-28-32-47-100)113-90(132)73(49-59(2)3)114-91(133)74(50-60(4)5)115-93(135)76(52-64-41-43-66(122)44-42-64)108-83(126)57-106-86(128)62(8)107-96(138)79(58-120)118-94(136)78(54-80(101)123)116-92(134)75(51-61(6)7)117-97(139)84(63(9)121)119-95(137)77(109-82(125)56-103-10)53-65-55-105-68-35-25-24-34-67(65)68/h24-25,34-35,41-44,55,59-63,69-79,84,103,105,120-122H,11-23,26-33,36-40,45-54,56-58,98-100H2,1-10H3,(H2,101,123)(H2,102,127)(H,104,124)(H,106,128)(H,107,138)(H,108,126)(H,109,125)(H,110,129)(H,111,131)(H,112,130)(H,113,132)(H,114,133)(H,115,135)(H,116,134)(H,117,139)(H,118,136)(H,119,137)/t62-,63+,69-,70-,71-,72-,73-,74-,75-,76-,77-,78-,79-,84-/m0/s1 |
PubChem CID | 25180498 |
ChEMBL | CHEMBL524892 |
IUPHAR | N/A |
BindingDB | 50273365 |
DrugBank | N/A |
Structure | ![]() |
Lipinski's druglikeness | This ligand has more than 5 hydrogen bond donor. This ligand has more than 10 hydrogen bond acceptor. This ligand is heavier than 500 daltons. This ligand has a partition coefficient log P greater than 5. |
Parameter | Value | Reference | Database source |
---|---|---|---|
Ki | 1323.5 nM | PMID19053761 | ChEMBL |
Ki | 1324.0 nM | PMID19053761 | BindingDB |
zhanglabzhanggroup.org | (734) 647-1549 | 100 Washtenaw Avenue, Ann Arbor, MI 48109-2218